A new animal health partnership platform aimed at finding better ways of preventing and managing disease and advancing sustainable animal agriculture and welfare has been established by Pfizer Animal Health and the Easter Bush Research Consortium.
A new animal health partnership platform aimed at finding better ways of preventing and managing disease and advancing sustainable animal agriculture and welfare has been established by Pfizer Animal Health and the Easter Bush Research Consortium (EBRC) – one of the largest veterinary research and education consortiums in Europe.
The new initiative, which will be backed by funding of approximately US$2m over five years, was formally launched in Scotland when The Princess Royal visited the University of Edinburgh‘s Easter Bush campus.
The collaboration will involve the four EBRC partners: the Moredun Research Institute; The Roslin Institute; The Royal (Dick) School of Veterinary Studies at the University of Edinburgh and SAC (Scottish Agricultural College).
It forms part of the Pfizer Partnership Platform, a unique partnership between the animal health industry, research institutions, agricultural colleges and academia. The venture aims to promote excellence in veterinary research and education.
Pfizer Partnership Platform objectives with the EBRC include:
- Advance veterinary educational activities;
- Support early stage research, PhDs, technologies and capability platforms;
- Promote veterinarians in postgraduate study and research;
- Promote multi-disciplinary research teams, with contributions from different participating organisations.
Projects are set to cover all major food production and companion animal species and will include vaccines, immunology, infectious diseases, parasitology, proteomics, genetics, genomics, antigenomics, target identification, clinical models and comparative translational medicine.
Prof Elaine Watson, head of the Royal (Dick) School of Veterinary Studies, said: “This partnership will provide the financial investment to develop world class veterinary education in a research-led environment and ensure that Edinburgh grows as a centre for international scientific excellence and knowledge transfer.
“The EBRC has a wealth of expertise and this agreement ensures a critical mass of inquiry for animal health and welfare issues, which will encourage new multi-disciplinary collaborations as well as provide training for the next generation of vets and scientists.”
The partnership will also support PhD candidates, allowing students to draw upon a wealth of expertise from across the EBRC’s four organisations. Students will be able to broaden their skills with knowledge that can be applied to future careers in academia, the pharmaceutical industry or government.
Albert Bourla, president of the EuAfME region at Pfizer Animal Health, said: “The time when industry could research and develop its own ideas and products in isolation is coming to an end; the future of animal health and welfare lies in multi-disciplinary collaboration with external partners who share the same vision.”
Together, Pfizer and the EBRC aim to encourage leading veterinary scientists from different organisations to share information and insights and work together on defined research and education projects that foster and accelerate innovation in the animal health sector.